Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia

Ageing Res Rev. 2024 Feb 26:102250. doi: 10.1016/j.arr.2024.102250. Online ahead of print.ABSTRACTDementia has been faced with significant public health challenges and economic burdens that urges the need to develop safe and effective interventions. In recent years, an increasing number of studies have focused on the relationship between dementia and liver and pancreatic metabolic disorders that result in diseases such as diabetes, obesity, hypertension and dyslipidemia. Previous reports have shown that there is a plausible correlation between pathologies caused by hepatopancreatic dysfunctions and dementia. Glucose, insulin and IGF-1 metabolized in the liver and pancreas probably have an important influence on the pathophysiology of the most common dementias: Alzheimer's and vascular dementia. This current review highlights recent studies aimed at identifying convergent mechanisms, such as insulin resistance and other diseases, linked to altered hepatic and pancreatic metabolism, which are capable of causing brain changes that ultimately lead to dementia.PMID:38417711 | DOI:10.1016/j.arr.2024.102250
Source: Ageing Research Reviews - Category: Genetics & Stem Cells Authors: Source Type: research